Drug intelligence / Profile preview

hypericum extract WS 5570

Development stage
Unknown
Lead developer
Schwabe
Modality
Small Molecules
Administration
Oral
01

Overview

Hypericum extract WS 5570 is a standardized dry herbal extract derived from the flowering tops of *Hypericum perforatum* (St. John’s wort). It is produced using an extraction solvent of methanol (80% v/v) with a drug-to-extract ratio of approximately 3–7:1[7]. The main active constituents are believed to be hyperforin and hypericin, which contribute to its pharmacological effects. WS 5570 acts as an antidepressant and has demonstrated efficacy in multiple randomized controlled trials for the acute treatment of mild to moderate major depression, with some evidence supporting use in moderate to severe cases as well[1][2][3][6]. Its mechanism involves inhibition of the reuptake of neurotransmitters such as serotonin, norepinephrine, and dopamine in the central nervous system. The safety profile is favorable; adverse event rates are similar to placebo and lower than those seen with synthetic antidepressants like paroxetine[1][3]. WS 5570 is approved for use in Germany for depression treatment and has been studied both for acute episodes and continuation/maintenance therapy after recovery from depression[1]. Caution is advised when used alongside other medications due to potential drug interactions mediated by induction or inhibition of cytochrome P450 enzymes and P-glycoprotein transporters[4].

Brand names
WS 5570WS5570WS-5570
Other names
Hypericum extract WS 5570St. John's Wort extract WS 5570St. John's Wort (Chinese name: 圣约翰草)
02

Targets

NET (Norepinephrine Transporter)SERT (Sodium-dependent serotonin transporter)DAT (Dopamine plasma membrane transport protein)MTNR1A (MT1)MTNR1B (Melatonin Receptor 2)

Beyond the preview

Go deeper on hypericum extract WS 5570.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on hypericum extract WS 5570.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call